Top Markets
Coin of the day
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
주식 순위 #39915
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
주가
$0.00366968
마지막 동기화: 2024-07-12
시가총액
$299.46K
변동 (1일)
-66.77%
변동 (1년)
0.00%
국가
CA
거래 Biocure Technology Inc. (CURE)

카테고리

Biocure Technology Inc. (CURE)의 주가 이력
최고 종가: $0.00 (2024-07-01 기준)

최저 종가: $0.01 (2009-03-01 기준)
Biocure Technology Inc.의 주가 이력 (2009 ~ 2026)
연간 주가 성과
연도 성과
2024 -66.52%
2023 45.61%
2022 -93.00%
2021 -11.53%
2020 -23.85%
2019 -54.33%
2018 42.23%
2017 3,176.92%
2016 2.72%
2015 68.45%
2014 -68.19%
2013 -16.07%
2012 -65.37%
2011 376.76%
2010 -26.05%
2009 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.15%
KR
$259.89 14.81%
BE